Gensight Biologics SA (SIGHT) - Total Liabilities

Latest as of June 2025: €39.46 Million EUR ≈ $46.13 Million USD

Based on the latest financial reports, Gensight Biologics SA (SIGHT) has total liabilities worth €39.46 Million EUR (≈ $46.13 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Gensight Biologics SA generate cash to assess how effectively this company generates cash.

Gensight Biologics SA - Total Liabilities Trend (2012–2024)

This chart illustrates how Gensight Biologics SA's total liabilities have evolved over time, based on quarterly financial data. Check Gensight Biologics SA (SIGHT) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Gensight Biologics SA Competitors by Total Liabilities

The table below lists competitors of Gensight Biologics SA ranked by their total liabilities.

Company	Country	Total Liabilities
ZOONO Group Ltd AU:ZNO	Australia	AU$2.53 Million
Amj Land Holdings Limited NSE:AMJLAND	India	Rs430.04 Million
GP Petroleums Limited NSE:GULFPETRO	India	Rs591.82 Million
Crescent NV BR:OPTI	Belgium	€15.84 Million
Flexion Mobile PLC ST:FLEXM	Sweden	Skr20.59 Million
Sporting Clube de Braga - Futebol SAD LS:SCB	Portugal	€176.79 Million
Celsius Resources Ltd AU:CLA	Australia	AU$5.65 Million
Ihlas Yayin Holding A.S. IS:IHYAY	Turkey	TL2.77 Billion

Liability Composition Analysis (2012–2024)

This chart breaks down Gensight Biologics SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Gensight Biologics SA (SIGHT) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.11	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.23	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	5.37	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Gensight Biologics SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Gensight Biologics SA (2012–2024)

The table below shows the annual total liabilities of Gensight Biologics SA from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	€37.68 Million ≈ $44.05 Million	-5.42%
2023-12-31	€39.83 Million ≈ $46.57 Million	-3.36%
2022-12-31	€41.22 Million ≈ $48.19 Million	+1.38%
2021-12-31	€40.66 Million ≈ $47.53 Million	+13.91%
2020-12-31	€35.69 Million ≈ $41.73 Million	+72.13%
2019-12-31	€20.74 Million ≈ $24.24 Million	+58.19%
2018-12-31	€13.11 Million ≈ $15.33 Million	+81.67%
2017-12-31	€7.22 Million ≈ $8.44 Million	+22.51%
2016-12-31	€5.89 Million ≈ $6.89 Million	-15.66%
2015-12-31	€6.98 Million ≈ $8.16 Million	+64.81%
2014-12-31	€4.24 Million ≈ $4.95 Million	+122.31%
2013-12-31	€1.91 Million ≈ $2.23 Million	+1399.90%
2012-12-31	€127.08K ≈ $148.57K	--

About Gensight Biologics SA

PA:SIGHT France Biotechnology

Market Cap

$21.50 Million

€18.39 Million EUR

Market Cap Rank

#25281 Global

#414 in France

Share Price

€0.08

Change (1 day)

-2.00%

52-Week Range

€0.08 - €0.26

All Time High

€9.58